Treatment on ankylosing spondylitis at active stage with combination moxibustion and modified Wuteng Decoction

Objective: To observe the clinical efficacy and safety of combination moxibustion and modified Wuteng Decoction in the treatment of patients with ankylosing spondylitis at active stage. Methods: Forty-two patients with ankylosing spondylitis at active stage were included and treated with combination moxibustion and Wuteng Decoction. Moxibustion points included points in governor vessel, Taiyang bladder meridian of foot and Jiaji points. Patients were treated with moxibustion 3 times per week and Wuteng Decoction 1 dose a day. A month as a treatment course, the treatment lasted for 3 treatment courses. Clinical indicators, laboratory indexs, safety indexs, and the clinical curative effect were observed. Results: 1Eight cases of patients were relieved, 21 patients had achieved significant results, 10 patients were effective, and 3 patients were invalid. The total effective rate was 92.86%. The BASDAI, BASFI, thoracic mobility, Schober experiment, finger-floor distance, occiputwall distance, ESR and CRP were improved significantly compared with treatment before(P0.05, P0.01). 2There were not significant adverse reactions in patients. Conclusion: Combination moxibustion and modified Wuteng Decoction could improve BASDAI, BASFI, thoracic mobility, Schober experiment, finger-floor Distance, occiput-wall distance, ESR and CRP of patients, and with higher effective rate, fewer adverse reaction, better security, which is worthy of clinical promotion.